{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Euplotes : Questions médicales les plus fréquentes",
"headline": "Euplotes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Euplotes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-12",
"dateModified": "2025-02-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Euplotes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sporadotrichina",
"url": "https://questionsmedicales.fr/mesh/D016811",
"about": {
"@type": "MedicalCondition",
"name": "Sporadotrichina",
"code": {
"@type": "MedicalCode",
"code": "D016811",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.043.185.700.400.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Euplotes",
"alternateName": "Euplotes",
"code": {
"@type": "MedicalCode",
"code": "D016812",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Adriana Vallesi",
"url": "https://questionsmedicales.fr/author/Adriana%20Vallesi",
"affiliation": {
"@type": "Organization",
"name": "School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, MC, Italy. adriana.vallesi@unicam.it."
}
},
{
"@type": "Person",
"name": "Pierangelo Luporini",
"url": "https://questionsmedicales.fr/author/Pierangelo%20Luporini",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Eukaryotic Microbiology and Animal Biology, School of Biosciences and Veterinary Medicine, University of Camerino, Camerino 62032, Italy."
}
},
{
"@type": "Person",
"name": "Yaohan Jiang",
"url": "https://questionsmedicales.fr/author/Yaohan%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, MC, Italy; Institute of Evolution & Marine Biodiversity, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Claudia Vannini",
"url": "https://questionsmedicales.fr/author/Claudia%20Vannini",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Pisa, Pisa, 56126, Italy."
}
},
{
"@type": "Person",
"name": "Graziano Di Giuseppe",
"url": "https://questionsmedicales.fr/author/Graziano%20Di%20Giuseppe",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Pisa, Pisa, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Questions raised by a case of adult-onset linear nodular scleroderma.",
"datePublished": "2022-10-15",
"url": "https://questionsmedicales.fr/article/36809134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5070/D328559245"
}
},
{
"@type": "ScholarlyArticle",
"name": "Management Options for Linear Scleroderma (\"En Coup de Sabre\").",
"datePublished": "2022-07-22",
"url": "https://questionsmedicales.fr/article/35985009",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DSS.0000000000003539"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma and Raynaud Phenomenon: The Cold Truth Regarding the Use of Operative Management.",
"datePublished": "2022-05-10",
"url": "https://questionsmedicales.fr/article/35544320",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/PRS.0000000000009187"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis.",
"datePublished": "2022-07-31",
"url": "https://questionsmedicales.fr/article/35921989",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.autrev.2022.103162"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36304460",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1004949"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Alveolata",
"item": "https://questionsmedicales.fr/mesh/D056893"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ciliophora",
"item": "https://questionsmedicales.fr/mesh/D016798"
},
{
"@type": "ListItem",
"position": 5,
"name": "Polymenophorea",
"item": "https://questionsmedicales.fr/mesh/D016809"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hypotrichida",
"item": "https://questionsmedicales.fr/mesh/D016810"
},
{
"@type": "ListItem",
"position": 7,
"name": "Sporadotrichina",
"item": "https://questionsmedicales.fr/mesh/D016811"
},
{
"@type": "ListItem",
"position": 8,
"name": "Euplotes",
"item": "https://questionsmedicales.fr/mesh/D016812"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Euplotes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Euplotes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Euplotes",
"description": "Comment identifier les Euplotes dans un échantillon d'eau ?\nQuels tests sont utilisés pour étudier les Euplotes ?\nLes Euplotes peuvent-ils être confondus avec d'autres organismes ?\nQuels outils sont nécessaires pour le diagnostic des Euplotes ?\nQuelle est la taille typique des Euplotes ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Localized&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Euplotes",
"description": "Quels symptômes sont associés aux infections par Euplotes ?\nLes Euplotes provoquent-ils des maladies chez l'homme ?\nQuels effets les Euplotes ont-ils sur les écosystèmes aquatiques ?\nLes Euplotes peuvent-ils affecter d'autres organismes aquatiques ?\nComment les Euplotes se déplacent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Localized&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Euplotes",
"description": "Comment prévenir la prolifération des Euplotes dans les étangs ?\nQuelles mesures peuvent réduire les Euplotes dans les aquariums ?\nLes Euplotes peuvent-ils être introduits accidentellement ?\nComment éviter la contamination des eaux par les Euplotes ?\nLes Euplotes sont-ils affectés par les traitements de l'eau ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Localized&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Euplotes",
"description": "Quels traitements sont disponibles pour les infections par Euplotes ?\nComment contrôler les populations d'Euplotes dans les aquariums ?\nLes Euplotes nécessitent-ils des soins particuliers en laboratoire ?\nQuels produits chimiques affectent les Euplotes ?\nLes Euplotes sont-ils sensibles aux changements de température ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Localized&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Euplotes",
"description": "Quelles complications peuvent survenir avec les Euplotes ?\nLes Euplotes peuvent-ils causer des déséquilibres écologiques ?\nComment les Euplotes affectent-ils la biodiversité ?\nLes Euplotes sont-ils un indicateur de pollution ?\nLes Euplotes peuvent-ils être nuisibles aux poissons ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Localized&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Euplotes",
"description": "Quels facteurs augmentent la présence des Euplotes ?\nLes changements climatiques affectent-ils les Euplotes ?\nLes Euplotes sont-ils sensibles à la pollution ?\nQuels types d'eaux favorisent les Euplotes ?\nLes Euplotes sont-ils affectés par les activités humaines ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Localized&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les Euplotes dans un échantillon d'eau ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'observation microscopique permet de détecter les Euplotes grâce à leur forme caractéristique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour étudier les Euplotes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de culture et des tests de coloration sont souvent utilisés pour les identifier."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils être confondus avec d'autres organismes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec d'autres protozoaires ciliés sans une observation minutieuse."
}
},
{
"@type": "Question",
"name": "Quels outils sont nécessaires pour le diagnostic des Euplotes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un microscope à lumière et des préparations d'échantillons sont essentiels pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quelle est la taille typique des Euplotes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les Euplotes mesurent généralement entre 50 et 200 micromètres de long."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux infections par Euplotes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections par Euplotes sont rares, mais peuvent causer des troubles digestifs chez les hôtes."
}
},
{
"@type": "Question",
"name": "Les Euplotes provoquent-ils des maladies chez l'homme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les Euplotes ne sont pas pathogènes pour l'homme et ne causent pas de maladies."
}
},
{
"@type": "Question",
"name": "Quels effets les Euplotes ont-ils sur les écosystèmes aquatiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils jouent un rôle dans la chaîne alimentaire et la décomposition des matières organiques."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils affecter d'autres organismes aquatiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer la population d'autres protozoaires et microorganismes dans leur habitat."
}
},
{
"@type": "Question",
"name": "Comment les Euplotes se déplacent-ils ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils se déplacent grâce à des cils qui battent de manière coordonnée, leur permettant de nager."
}
},
{
"@type": "Question",
"name": "Comment prévenir la prolifération des Euplotes dans les étangs ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'eutrophisation et maintenir un bon équilibre écologique aide à prévenir leur prolifération."
}
},
{
"@type": "Question",
"name": "Quelles mesures peuvent réduire les Euplotes dans les aquariums ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un entretien régulier et un contrôle de la qualité de l'eau sont essentiels pour limiter leur croissance."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils être introduits accidentellement ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être introduits par des plantes aquatiques ou des équipements contaminés."
}
},
{
"@type": "Question",
"name": "Comment éviter la contamination des eaux par les Euplotes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter de relâcher des eaux usées non traitées dans les milieux aquatiques prévient leur introduction."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils affectés par les traitements de l'eau ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements de l'eau peuvent réduire leur population, mais doivent être utilisés avec précaution."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections par Euplotes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun traitement spécifique n'est nécessaire, car les Euplotes ne sont pas pathogènes pour l'homme."
}
},
{
"@type": "Question",
"name": "Comment contrôler les populations d'Euplotes dans les aquariums ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne qualité de l'eau et éviter la surpopulation aide à contrôler leur nombre."
}
},
{
"@type": "Question",
"name": "Les Euplotes nécessitent-ils des soins particuliers en laboratoire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils doivent être cultivés dans des conditions spécifiques pour assurer leur survie en laboratoire."
}
},
{
"@type": "Question",
"name": "Quels produits chimiques affectent les Euplotes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des désinfectants et des antibiotiques peuvent affecter leur survie dans des environnements aquatiques."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils sensibles aux changements de température ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les variations de température peuvent influencer leur croissance et leur reproduction."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les Euplotes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les Euplotes ne causent généralement pas de complications, car ils ne sont pas pathogènes pour l'homme."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils causer des déséquilibres écologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surpopulation d'Euplotes peut perturber l'équilibre des écosystèmes aquatiques."
}
},
{
"@type": "Question",
"name": "Comment les Euplotes affectent-ils la biodiversité ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer la biodiversité en interagissant avec d'autres microorganismes aquatiques."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils un indicateur de pollution ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur présence peut indiquer des niveaux de pollution dans les environnements aquatiques."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils être nuisibles aux poissons ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, ils ne sont pas nuisibles aux poissons, mais une surpopulation peut affecter leur habitat."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent la présence des Euplotes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eutrophisation et la pollution des eaux favorisent la prolifération des Euplotes."
}
},
{
"@type": "Question",
"name": "Les changements climatiques affectent-ils les Euplotes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les changements climatiques peuvent influencer leur habitat et leur reproduction."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils sensibles à la pollution ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pollution peut affecter leur survie et leur reproduction dans les milieux aquatiques."
}
},
{
"@type": "Question",
"name": "Quels types d'eaux favorisent les Euplotes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les eaux riches en nutriments et stagnantes sont idéales pour la prolifération des Euplotes."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils affectés par les activités humaines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les activités humaines comme l'agriculture et l'urbanisation peuvent augmenter leur présence."
}
}
]
}
]
}
Morphea presenting clinically with nodular or keloidal skin changes is extremely rare. Nodular scleroderma or keloidal morphea presenting in a linear distribution is even more uncommon. We present an ...
En coup de sabre (ECDS) is a form of linear-scleroderma, primarily affecting the face. Despite effectiveness of pharmacological interventions in the management of lesions, sequelae of cutaneous deform...
Review the existing surgical tools for the correction of "en coup de sabre" ECDS lesions and facial deformities....
The authors conducted a literature search for reports on surgical interventions for ECDS deformations, in the electronic databases of PubMed, Scopus, and Cochrane Library Databases....
Twenty-six publications reporting 39 patients were found in the literature. The average age of patients was 25 ± 4.7 years. Thirty-one of the patients were females. Six methods were found in the liter...
Different surgical and minimally invasive options exist in the armamentarium of clinicians correcting ECDS deformities. Tailoring the method of correction to patient's needs and expectation is crucial...
Raynaud phenomenon, with and without scleroderma, is a common vasospastic condition that manifests with extremity pain and skin discoloration. When conservative management fails, complications such as...
A national insurance claims-based database with patient records from the Centers for Medicare and Medicaid Services was used for data collection. Patients with first diagnoses of Raynaud phenomenon, s...
The Raynaud phenomenon, scleroderma, and Raynaud phenomenon with scleroderma cohorts consisted of 161,300, 117,564, and 25,096 patients, respectively. A diagnosis of both Raynaud phenomenon and sclero...
Patients with both Raynaud phenomenon and scleroderma have higher likelihoods of having upper extremity amputations, vascular procedures, and amputations following vascular procedures compared to each...
Risk, II....
To describe systemic sclerosis (SSc) heart involvement in the ICU....
We retrospectively studied patients with previous diagnosis of SSc admitted to the ICU for acute cardiac dysfunction between 2012 and mid-2021....
9 female patients were included, mainly with diffuse SSc (n = 7, 78%). Six (67%) had digital ulcers. All but one patient complained about physical cardiac symptoms (n = 8, 89%), 5 (56%) had electrocar...
We report an uncommon and specific severe acute life-threatening cardiac dysfunction in SSc patients, which can be reversible but remains associated with a poor long-term prognosis, which can be rever...
Recent evidence has indicated that alterations in energy metabolism play a critical role in the pathogenesis of fibrotic diseases. Studies have suggested that 'metabolic reprogramming' involving the g...
Dermal fibroblasts were isolated from five SSc patients and five healthy donors. Cells were cultured in medium with/without TGF-β1 and with/without ALK5, pan-PIM or ATM kinase inhibitors. Extracellula...
Enhanced mitochondrial respiration coupled to ATP production was observed in SSc fibroblasts at the expense of spare respiratory capacity. Although no difference was found in glycolysis when comparing...
Our data provide evidence for a novel mechanism(s) by which SSc fibroblasts exhibit altered metabolic programs and highlight changes in respiration and dysregulated mitochondrial morphology and functi...
Localized scleroderma (LS), also called circumscribed scleroderma or morphea, comprises a heterogeneous group of diseases that can be classified into four subtypes: limited, linear, generalized, and m...
Patients with diffuse cutaneous systemic sclerosis (dcSSc) display a complex clinical phenotype. Transcriptional profiling of whole blood or tissue from patients are affected by changes in cellular co...
SSc patients were recruited from the Prospective Registry for Early Systemic Sclerosis. Clinical data were collected, as well as peripheral blood for isolation of CMs and NCMs. Age-, sex-, and race-ma...
We used an unbiased approach to cluster patients into 3 groups (groups A-C) based on the transcriptional signatures of CMs relative to controls. Each group maintained their characteristic transcriptio...
We are the first to show that transcriptional signatures of CMs and NCMs can be used to unbiasedly stratify SSc patients and correlate with disease activity outcome measures....
Scleroderma renal crisis (SRC) is a rare and severe manifestation of systemic sclerosis (SSc). Although it is well documented that Black patients with SSc have worse morbidity and mortality than non-B...
Using the electronic health record of the US Military Health System, we conducted a comprehensive chart review of each patient with SSc from 2005 to 2016. The final study cohort was comprised of 31 SR...
Of 353 patients, 294 had identifiable race (79 Black, 215 non-Black). Thirteen of 79 Black patients (16.5%) versus 16 of 215 (7.4%) non-Black patients developed SRC (P = 0.02). On adjusted analysis, B...
Black race was independently associated with a higher risk of future SRC. Further studies are needed to elucidate the mechanisms that underlie this important association....
Nailfold videocapillaroscopy is the gold standard for the early differentiation of primary and secondary Raynaud's phenomenon. Advances in high-frequency ultrasound with superb microvascular imaging s...
Pulmonary arterial hypertension (PAH) is a severe, high mortality and progressive disease. Early diagnosis and treatment improves the prognosis. Patients with scleroderma disease presents high risk of...
Prospective study of 52 consecutive patients diagnosed of scleroderma in our health area, during 2 years (2018 and 2019). All of them undergo CPET, in addition to the annual systematic screening. Sens...
Fifty-two CPET were performed, of which 16 suggested PAH. Resting RHC confirmed PAH in 5 patients and exercise RHC in 7 (diagnostic sensitivity of CPET together with rest and exercise catheterization ...
CPET and exercise RHC could detect PAH earlier than established screening in patients with scleroderma disease, allowing early diagnosis....